Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

(OP:BMNDF)

0.7000 UNCHANGED
Last Price Updated: 9:30 AM EST, Jan 13, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 0.7000
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 0.7000
Today's Range 0.7000 - 0.7000
52wk Range 0.0890 - 0.7000
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Biomind Labs Welcomes U.S. Policy Shift as a Historic Milestone for Psychedelic Therapies
Via ACCESSWIRE
Biomind Labs To Redefine Obesity Treatment With Its New BMND06 Candidate Targeting Neurological Pathways
Via ACCESSWIRE

Performance

YTD
N/A
N/A
1 Month
N/A
N/A
3 Month
N/A
N/A
6 Month
+133.3%
+133.3%
1 Year
+686.5%
+686.5%

More News

Read More
Biomind Labs Completes the Development of the First 5-MeO-DMT Organic Synthesis Scheme for Pharmaceutical Applications
From Biomind Labs Inc.
Via Business Wire
Cybin, GH Research Among Top Psychedelic Movers Of Today
Via Benzinga
Psychedelic Stock Gainers And Losers From January 26, 2023
Via Benzinga
Biomind Labs, Intelgenx Technologies Among Top Psychedelic Movers Of Today
Via Benzinga
Psychedelic Stock Gainers And Losers From January 24, 2023
Via Benzinga
New Sublingual Psychedelic Drug Candidate Created For Depression And Anxiety In Alzheimer's
Via Benzinga
Psychedelic Stock Gainers And Losers From November 22, 2022
Via Benzinga
Psyched: Musk's Empathy Tweets, Psychedelics In Congress, Oregon's Opt-Outs, MAPS' MDMA Trial And More
Via Benzinga
Psychedelic Stock Gainers And Losers From November 21, 2022
Via Benzinga
Biomind Labs, ATAI Life Sciences Among Top Psychedelic Movers Of Today
Via Benzinga
Revive Therapeutics, GH Research Among Top Psychedelic Movers Of Today
Via Benzinga
Psychedelic Stock Gainers And Losers From November 16, 2022
Via Benzinga
GH Research, Seelos Therapeutics Among Top Psychedelic Movers Of Today
Via Benzinga
Biomind Labs: Q3 Financials & FDA Approval For New Chemical Entity Targeting Treatment-Resistant Depression
Via Benzinga
Compass Pathways, Mind Medicine Among Top Psychedelic Movers Of Today
Via Benzinga
Seelos Therapeutics, GH Research Among Top Psychedelic Movers Of Today
Via Benzinga
Psychedelic Stock Gainers And Losers From November 8, 2022
Via Benzinga
Compass Pathways, Allied Among Top Psychedelic Movers Of Today
Via Benzinga
Next-Gen Psychedelic Delivers Promising Results For Treatment-Resistant Depression In Phase 2 Clinical Trial
Via Benzinga
Psychedelic Stock Gainers And Losers From November 3, 2022
Via Benzinga
Compass Pathways, Small Pharma Among Top Psychedelic Movers Of Today
Via Benzinga
Revive Therapeutics, Small Pharma Among Top Psychedelic Movers Of Today
Via Benzinga
Psychedelic Stock Gainers And Losers From October 26, 2022
Via Benzinga

Frequently Asked Questions

Is BMNDF publicly traded?
Yes, BMNDF is publicly traded.
What exchange does BMNDF trade on?
BMNDF trades on the OTC Traded
What is the ticker symbol for BMNDF?
The ticker symbol for BMNDF is BMNDF on the OTC Traded
What is the current price of BMNDF?
The current price of BMNDF is 0.7000
When was BMNDF last traded?
The last trade of BMNDF was at 01/13/25 09:30 AM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.